µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© x_#'6H\1ga
?]0bR]}y
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© qIk(ei
1¡¢Co-stimulators (or co-stimulating molecules) 1p(9hVA
2¡¢NK-kB Y{
w9D`}
3¡¢Immunoglobulin superfamily @O)1Hnm
4¡¢antigen-presenting cell (APC) /qweozW_+
5¡¢death domain |/;X-+f8
6¡¢CCR and CXCR y@\J7 h:
7¡¢Lectin (or mitogen) 94L>%{59
8¡¢Clusters of differentiation, CD) n4
J*04K
9¡¢B7 family (BY5omlh
10¡¢Cytotoxic T lymphocyte, CTL) gU@BEn}
11¡¢IL-15 and IL-15 receptor (IL-15R) Hw~?%g:<S
12¡¢MHC restriction Fd >epvR
13¡¢Affinity-chromatography rF=\H3`p3
14¡¢Cyctosprin A, CsA Y
I),yj
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) >\Ml\CyL
!k8j8v&
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© dU#}Tk
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 Og(|bs!6
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ >e QFY^d5
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 jCL 1Bj
N
m@UM*D
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© xRm~a-rp
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ z460a[Wl
ѪҺ²¡Ñ§×¨Òµ£º 4_h?E:sBb
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿